查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827739

2025年萤光萤光分析全球市场报告

Immunofluorescence Assay Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，萤光检测市场规模强劲成长，从2024年的33.4亿美元成长到2025年的35.6亿美元，复合年增长率为6.5%。历史时期的成长归因于疾病诊断的增加、研发的增加、自体免疫疾病的增加、癌症诊断的增加以及病毒学研究的增加。

预计未来几年萤光萤光检测市场将快速成长，到2029年将达到53.2亿美元，复合年增长率为10.6%。预测期内的成长归因于个人化医疗的兴起、感染疾病监测的加强、自体免疫疾病盛行率的上升、就地检验的增加以及全球卫生防备水准的提高。预测期内的主要趋势包括多重检测、自动化和机器人技术、高内涵成像、先进的萤光染料以及数位病理学整合。

萤光检测包括利用此技术观察受感染细胞内特定蛋白质或抗原的设备和耗材。这种观察是透过将这些蛋白质或抗原与化学偶联萤光染料的特异性抗体发生反应来实现的。此实验室技术用于诊断影响各种器官系统的疾病，包括皮肤、肾臟、心臟和纤毛。

萤光检测的主要类型是直接萤光和间接萤光。直接萤光是一种用于诊断疾病的实验室技术，特别是与皮肤、肾臟和其他器官系统相关的疾病。此方法利用与萤光染料直接偶联的单一抗体。萤光检测类别涵盖各种各样的产品，包括试剂、仪器、抗体、套件、耗材和配件。这些产品用于诊断各种疾病，包括癌症、感染疾病和自体免疫疾病。所调查的目标产品用于学术和研究机构、製药和生物技术公司、医院、诊断中心以及合约研究组织。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供萤光测定市场统计数据，包括萤光测定行业的全球市场规模、各地区市场份额、各竞争对手的市场份额、详细的萤光萤光测定市场细分、市场趋势和商机，以及您在萤光测定行业取得成功所需的数据。本萤光测定市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年预测成长率为10.6%，较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自英国和加拿大等主要地区的萤光标记二抗和高解析度萤光显微镜征收关税英国影响美国，从而导致诊断准确性降低和病理检测成本上升。此外，透过互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，这种影响也将更为广泛地显现。

萤光萤光检测市场的强劲成长很大程度上归功于慢性病的日益普及。生活方式的改变、饮食习惯的改变以及不适当的体重管理导致慢性病发病率激增，而长期感染疾病则会增加癌症风险。由于萤光检测在慢性病诊断和药物研发的广泛应用，其需求正在不断增长。根据美国美国十个成年人中就有六人患有慢性病，每年的医疗费用高达3.8兆美元。因此，预计慢性病的流行将在整个预测期内推动萤光检测的需求成长。

由于个人化医疗需求的不断增长，萤光检测市场预计将进一步成长。个人化医疗利用个体的基因图谱为疾病预防、诊断和治疗相关的决策提供信息，这在很大程度上依赖于萤光检测。这些检测在识别特定生物标记方面发挥关键作用，而这些生物标记对于制定个人化治疗计划至关重要。根据个人化医疗联盟的报告，将有超过 75,000 种基因检测产品和 300 多种个人化药物可用于治疗各种疾病，包括癌症、罕见遗传疾病、慢性病和感染疾病。因此，个人化医疗需求的不断增长正在推动萤光萤光检测市场的成长。

萤光检测市场的一个显着趋势是注重技术进步。该领域的公司致力于利用先进技术开发创新产品，尤其致力于针对新发病毒（如COVID-19）的诊断。总部位于英国的照护现场开发商LumiraDx于2022年3月获得其LumiraDx SARS-CoV-2抗原检测的紧急核准，该检测是一种微流体萤光检测方法，用于定性检测鼻拭子样本中的核衣壳蛋白抗原。

萤光测定市场的主要企业正策略性地专注于推出全自动解决方案，以最大化市场收益。这些解决方案简化了整个萤光测试过程，从样品製备到孵育、清洗和玻片安装。 2023 年 6 月，美国生命科学和诊断公司 Levity 推出了 UNIQO 160 (CE-IVDR)，这是一种用于自体免疫疾病诊断的自动间接萤光测试 (IIFT) 系统。 UNIQO 160 是一种桌上型设备，它将自动化处理与高品质显微镜结合，一次运行最多可处理 160 个原始检体和 18 张玻片。该系统利用条码识别单一样本、试剂和载玻片。

2022年1月，美国生技公司赛默飞世尔科技（Thermo Fisher Scientific）以18.5亿美元收购了PeproTech。此次收购旨在透过将新功能整合到其生物科学业务中，增强赛默飞世尔科技对製药和生物技术客户的支援能力，这在不断变化的基因治疗领域至关重要。 PeproTech是一家总部位于美国的生命科学公司，提供重组蛋白和ELISA萤光套件。

萤光测定市场的主要公司包括 Thermo Fisher Scientific Inc.、Abcam plc、Bio-Rad Laboratories Inc.、PerkinElmer Inc.、Werfen Company、Merck KGaA、Danaher Corporation、Cell Signaling Technology Inc.、Vector Laboratories Inc.、INOVA Diagnostics Inc.、Sino Biological Inc. Inc.、Rockland Immunochemicals Inc.、Beshir Laboratories Inc.、Fitzgerald Industries International Inc.、 创新、Bostar Biological Technology、Acris Antibodies GmbH、RayBiotech Inc.、Proteintech Group Inc.、Novus Biologicals LLC、R&D Technology Inc.、Ogene Technologies CorporationS. Limited、J. Mitra &Co.Ltd.、EpiGentek Group Inc.、Elabscience Biotechnology Co.Ltd.、Aesku Diagnostics GmbH

预计北美将在2024年成为免疫萤光市场最大的地区，并有望成为预测期内成长最快的地区。萤光萤光检测市场份额报告涵盖以下地区：亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

萤光测定市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

萤光检测市场包括间接免疫萤光补体结合 (IF-CF) 和双重免疫萤光的销售。该市场的价值为「工厂门口」价值，即商品製造商或创造者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球萤光检测：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球萤光萤光分析市场：成长率分析
  • 全球萤光萤光分析市场表现：规模与成长，2019-2024
  • 全球萤光萤光分析市场预测：规模与成长，2024-2029年，2034年
  • 全球萤光检测：总潜在市场（TAM）

第六章 市场细分

  • 全球萤光萤光分析市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 直接萤光
  • 间接萤光
  • 全球萤光萤光分析市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 试剂
  • 装置
  • 抗体
  • 套件
  • 耗材及配件
  • 全球萤光萤光分析市场：依疾病、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 感染疾病
  • 心血管疾病
  • 自体免疫疾病
  • 其他疾病
  • 全球萤光萤光分析市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 学术研究机构
  • 製药和生物技术公司
  • 合约研究组织
  • 医院和诊断中心
  • 全球萤光萤光分析市场：依直接萤光细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单步直接测定
  • 多重直接分析
  • 全球萤光萤光分析市场：依间接萤光法细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单步间接测定
  • 多重间接检测

第七章 区域和国家分析

  • 全球萤光萤光分析市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球萤光萤光分析市场：依国家、表现及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 萤光萤光分析市场：竞争格局
  • 萤光萤光分析市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abcam plc Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Werfen Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Merck KGaA
  • Danaher Corporation
  • Cell Signaling Technology Inc.
  • Vector Laboratories Inc.
  • INOVA Diagnostics Inc.
  • Sino Biological Inc.
  • Medipan GmbH
  • BioLegend Inc.
  • Jackson ImmunoResearch Laboratories Inc.
  • Rockland Immunochemicals Inc.
  • Bethyl Laboratories Inc.
  • Fitzgerald Industries International Inc.
  • Creative Diagnostics
  • Boster Biological Technology
  • Acris Antibodies GmbH

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年萤光萤光分析市场：提供新机会的国家
  • 2029年萤光萤光分析市场：细分领域带来新机会
  • 2029年萤光萤光分析市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21629u

Immunofluorescence assay encompasses both equipment and consumables designed to utilize a technique allowing the visualization of specific proteins and antigens in infected cells. This visualization is achieved through the reaction of these proteins and antigens with specific antibodies, which are chemically conjugated with a fluorescent dye. This laboratory technique is employed in the diagnosis of diseases affecting various organ systems such as the skin, kidney, heart, cilia, and others.

The main types of immunofluorescence assay include direct immunofluorescence and indirect immunofluorescence. Direct immunofluorescence is a laboratory technique specifically used for diagnosing diseases related to the skin, kidney, and other organ systems. In this method, a single antibody directly conjugated to a fluorescent dye is utilized. The diverse range of products in the immunofluorescence assay category includes reagents, instruments, antibodies, kits, consumables, and accessories. These products are employed in the diagnosis of various diseases, including cancer, infectious diseases, autoimmune diseases, among others. Immunofluorescence assay products are utilized by academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, as well as contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The immunofluorescence assay market research report is one of a series of new reports from The Business Research Company that provides immunofluorescence assay market statistics, including immunofluorescence assay industry global market size, regional shares, competitors with an immunofluorescence assay market share, detailed immunofluorescence assay market segments, market trends and opportunities, and any further data you may need to thrive in the immunofluorescence assay industry. This immunofluorescence assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The immunofluorescence assay market size has grown strongly in recent years. It will grow from $3.34 billion in 2024 to $3.56 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increased disease diagnosis, rise in research and development, rise in autoimmune diseases, increased cancer diagnostics, rise in virology research.

The immunofluorescence assay market size is expected to see rapid growth in the next few years. It will grow to $5.32 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing personalized medicine, rising infectious disease surveillance, rising autoimmune disorders, rising point-of-care testing, increasing global health preparedness. Major trends in the forecast period include multiplexing assays, automation and robotics, high-content imaging, advanced fluorophores, digital pathology integration.

The forecast of 10.6% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on fluorophore-labeled secondary antibodies and high-resolution fluorescence microscopes, sourced from key regions such as the UK and Canada, which could lead to compromised diagnostic accuracy and higher pathology expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The robust growth of the immunofluorescence assay market is significantly attributed to the increasing prevalence of chronic diseases. Lifestyle changes, dietary habits, and inadequate weight management contribute to a surge in chronic conditions, with prolonged infections posing a risk of developing cancer. Immunofluorescence assays are witnessing heightened demand for their extensive use in the diagnosis and drug development activities associated with chronic diseases. A study from the Centers for Disease Control and Prevention reveals that around 6 in 10 adults in the USA are affected by chronic diseases, accounting for a substantial annual healthcare cost of $3.8 trillion. Therefore, the escalating prevalence of chronic diseases is anticipated to drive the demand for immunofluorescence assays throughout the forecast period.

The immunofluorescence assay market is poised for further growth due to the increasing demand for personalized medicines. Personalized medicine, utilizing an individual's genetic profile to inform decisions related to disease prevention, diagnosis, and treatment, relies heavily on immunofluorescence assays. These assays play a pivotal role in identifying specific biomarkers crucial for formulating personalized treatment plans. The Personalized Medicine Coalition reports that over 75,000 genetic testing products and 300 personalized medicines will be available for various conditions, including cancer, rare genetic diseases, and chronic and infectious diseases. Consequently, the rising demand for personalized medicines is propelling the growth of the immunofluorescence assay market.

A prominent trend in the immunofluorescence assay market is the emphasis on technological advancements. Companies in this sector are dedicated to developing innovative products with advanced technologies, especially for diagnostic purposes related to emerging viruses like COVID-19. LumiraDx, a UK-based developer of point-of-care diagnostics, received emergency approval for its microfluidic immunofluorescence assay, LumiraDx SARS-CoV-2 Ag Test, designed for the qualitative detection of nucleocapsid protein antigens from nasal swab samples in March 2022.

Major players in the immunofluorescence assay market are strategically focusing on introducing fully automated solutions to maximize their market revenues. Fully automated solutions streamline the entire immunofluorescence testing process, from sample preparation to incubation, washing, and slide mounting. Revvity Inc., a US-based life sciences and diagnostics company, launched UNIQO 160 (CE-IVDR), an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics in June 2023. UNIQO 160, a tabletop device, integrates automated processing with a high-quality microscope, capable of handling up to 160 main samples and 18 slides in a single run. The system utilizes barcode recognition for individual samples, reagents, and slides.

In January 2022, Thermo Fisher Scientific Inc., a US-based biotechnology firm, acquired PeproTech Inc. for $1.85 billion. This acquisition is intended to enhance Thermo Fisher Scientific Inc.'s ability to support its pharmaceutical and biotech clients by integrating new capabilities into its biosciences business, which is essential for the changing landscape of gene therapies. PeproTech Inc. is a US-based life science company that offers recombinant proteins and ELISA immunofluorescence kits.

Major companies operating in the immunofluorescence assay market include Thermo Fisher Scientific Inc., Abcam plc, Bio-Rad Laboratories Inc., PerkinElmer Inc., Werfen Company, Merck KGaA, Danaher Corporation, Cell Signaling Technology Inc., Vector Laboratories Inc., INOVA Diagnostics Inc., Sino Biological Inc., Medipan GmbH, BioLegend Inc., Jackson ImmunoResearch Laboratories Inc., Rockland Immunochemicals Inc., Bethyl Laboratories Inc., Fitzgerald Industries International Inc., Creative Diagnostics, Boster Biological Technology, Acris Antibodies GmbH, RayBiotech Inc., Proteintech Group Inc., Novus Biologicals LLC, R&D Systems Inc., OriGene Technologies Inc., GenScript Biotech Corporation, MBL International Corporation, Abnova Corporation, Cellabs India Technologies Limited, J. Mitra & Co. Pvt. Ltd., EpiGentek Group Inc., Elabscience Biotechnology Co. Ltd., Aesku.Diagnostics GmbH

North America was the largest region in the immunofluorescence assay market in 2024, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the immunofluorescence assay market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the immunofluorescence assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The immunofluorescence assay market consists of sales of indirect IF complement-fixation (IF-CF), and double IF. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunofluorescence Assay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunofluorescence assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunofluorescence assay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunofluorescence assay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Direct Immunofluorescence; Indirect Immunofluorescence
  • 2) By Product: Reagents; Instruments; Antibodies; Kits; Consumables and Accessories
  • 3) By Disease: Cancer; Infectious Disease; Cardiovascular Diseases; Autoimmune Diseases; Other Diseases
  • 4) By End User: Academic And Research Institutions; Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Hospitals And Diagnostic Centers
  • Subsegments:
  • 1) By Direct Immunofluorescence: Single-Step Direct Assays; Multiplex Direct Assays
  • 2) By Indirect Immunofluorescence: Single-Step Indirect Assays; Multiplex Indirect Assays
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abcam plc; Bio-Rad Laboratories Inc.; PerkinElmer Inc.; Werfen Company; Merck KGaA; Danaher Corporation; Cell Signaling Technology Inc.; Vector Laboratories Inc.; INOVA Diagnostics Inc.; Sino Biological Inc.; Medipan GmbH; BioLegend Inc.; Jackson ImmunoResearch Laboratories Inc.; Rockland Immunochemicals Inc.; Bethyl Laboratories Inc.; Fitzgerald Industries International Inc.; Creative Diagnostics; Boster Biological Technology; Acris Antibodies GmbH; RayBiotech Inc.; Proteintech Group Inc.; Novus Biologicals LLC; R&D Systems Inc.; OriGene Technologies Inc.; GenScript Biotech Corporation; MBL International Corporation; Abnova Corporation; Cellabs India Technologies Limited; J. Mitra & Co. Pvt. Ltd.; EpiGentek Group Inc.; Elabscience Biotechnology Co. Ltd.; Aesku.Diagnostics GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunofluorescence Assay Market Characteristics

3. Immunofluorescence Assay Market Trends And Strategies

4. Immunofluorescence Assay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Immunofluorescence Assay Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Immunofluorescence Assay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Immunofluorescence Assay Market Growth Rate Analysis
  • 5.4. Global Immunofluorescence Assay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Immunofluorescence Assay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Immunofluorescence Assay Total Addressable Market (TAM)

6. Immunofluorescence Assay Market Segmentation

  • 6.1. Global Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Immunofluorescence
  • Indirect Immunofluorescence
  • 6.2. Global Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents
  • Instruments
  • Antibodies
  • Kits
  • Consumables and Accessories
  • 6.3. Global Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Infectious Disease
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Other Diseases
  • 6.4. Global Immunofluorescence Assay Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutions
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations
  • Hospitals And Diagnostic Centers
  • 6.5. Global Immunofluorescence Assay Market, Sub-Segmentation Of Direct Immunofluorescence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Step Direct Assays
  • Multiplex Direct Assays
  • 6.6. Global Immunofluorescence Assay Market, Sub-Segmentation Of Indirect Immunofluorescence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Step Indirect Assays
  • Multiplex Indirect Assays

7. Immunofluorescence Assay Market Regional And Country Analysis

  • 7.1. Global Immunofluorescence Assay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Immunofluorescence Assay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunofluorescence Assay Market

  • 8.1. Asia-Pacific Immunofluorescence Assay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunofluorescence Assay Market

  • 9.1. China Immunofluorescence Assay Market Overview
  • 9.2. China Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunofluorescence Assay Market

  • 10.1. India Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunofluorescence Assay Market

  • 11.1. Japan Immunofluorescence Assay Market Overview
  • 11.2. Japan Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunofluorescence Assay Market

  • 12.1. Australia Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunofluorescence Assay Market

  • 13.1. Indonesia Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunofluorescence Assay Market

  • 14.1. South Korea Immunofluorescence Assay Market Overview
  • 14.2. South Korea Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunofluorescence Assay Market

  • 15.1. Western Europe Immunofluorescence Assay Market Overview
  • 15.2. Western Europe Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunofluorescence Assay Market

  • 16.1. UK Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunofluorescence Assay Market

  • 17.1. Germany Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunofluorescence Assay Market

  • 18.1. France Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunofluorescence Assay Market

  • 19.1. Italy Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunofluorescence Assay Market

  • 20.1. Spain Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunofluorescence Assay Market

  • 21.1. Eastern Europe Immunofluorescence Assay Market Overview
  • 21.2. Eastern Europe Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunofluorescence Assay Market

  • 22.1. Russia Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunofluorescence Assay Market

  • 23.1. North America Immunofluorescence Assay Market Overview
  • 23.2. North America Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunofluorescence Assay Market

  • 24.1. USA Immunofluorescence Assay Market Overview
  • 24.2. USA Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunofluorescence Assay Market

  • 25.1. Canada Immunofluorescence Assay Market Overview
  • 25.2. Canada Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunofluorescence Assay Market

  • 26.1. South America Immunofluorescence Assay Market Overview
  • 26.2. South America Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunofluorescence Assay Market

  • 27.1. Brazil Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunofluorescence Assay Market

  • 28.1. Middle East Immunofluorescence Assay Market Overview
  • 28.2. Middle East Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunofluorescence Assay Market

  • 29.1. Africa Immunofluorescence Assay Market Overview
  • 29.2. Africa Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunofluorescence Assay Market Competitive Landscape And Company Profiles

  • 30.1. Immunofluorescence Assay Market Competitive Landscape
  • 30.2. Immunofluorescence Assay Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abcam plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Werfen Company Overview, Products and Services, Strategy and Financial Analysis

31. Immunofluorescence Assay Market Other Major And Innovative Companies

  • 31.1. Merck KGaA
  • 31.2. Danaher Corporation
  • 31.3. Cell Signaling Technology Inc.
  • 31.4. Vector Laboratories Inc.
  • 31.5. INOVA Diagnostics Inc.
  • 31.6. Sino Biological Inc.
  • 31.7. Medipan GmbH
  • 31.8. BioLegend Inc.
  • 31.9. Jackson ImmunoResearch Laboratories Inc.
  • 31.10. Rockland Immunochemicals Inc.
  • 31.11. Bethyl Laboratories Inc.
  • 31.12. Fitzgerald Industries International Inc.
  • 31.13. Creative Diagnostics
  • 31.14. Boster Biological Technology
  • 31.15. Acris Antibodies GmbH

32. Global Immunofluorescence Assay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunofluorescence Assay Market

34. Recent Developments In The Immunofluorescence Assay Market

35. Immunofluorescence Assay Market High Potential Countries, Segments and Strategies

  • 35.1 Immunofluorescence Assay Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Immunofluorescence Assay Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Immunofluorescence Assay Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer